Psoriasis and comorbid diseases: epidemiology

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
Psoriasis is a common chronic inflammatory disease of the skin that is increasingly being
recognized as a systemic inflammatory disorder. Psoriatic arthritis is a well-known …

Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis

JJ Wu, A Kavanaugh, MG Lebwohl… - Journal of the …, 2022 - Wiley Online Library
Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled …

K Reich, M Gooderham, D Thaçi, JJ Crowley, C Ryan… - The Lancet, 2019 - thelancet.com
Background Psoriasis is an autoimmune disease that affects approximately 100 million
people worldwide, and is a disease that can be ameliorated by anti-cytokine treatment. We …

Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective …

S Schreiber, JF Colombel, BG Feagan… - Annals of the …, 2019 - ard.bmj.com
Objectives Here, we present the reported incidence rates of inflammatory bowel disease
(IBD) in patients receiving treatment with secukinumab for psoriasis (PsO), psoriatic arthritis …

Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies

AW Armstrong, CT Harskamp, EJ Armstrong - Journal of the American …, 2013 - Elsevier
BACKGROUND: Increasing population-based studies have suggested a relationship
between psoriasis and metabolic syndrome. OBJECTIVE: The objective of this study was to …

Genetic mapping in human disease

D Altshuler, MJ Daly, ES Lander - science, 2008 - science.org
Genetic mapping provides a powerful approach to identify genes and biological processes
underlying any trait influenced by inheritance, including human diseases. We discuss the …

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

NN Mehta, RS Azfar, DB Shin, AL Neimann… - European heart …, 2010 - academic.oup.com
Aims Psoriasis is a common chronic inflammatory T-helper cell-1/17 mediated skin disease.
Recent studies suggest that psoriasis, particularly if severe, may be an independent risk …

[HTML][HTML] Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment

SCS Hu, CCE Lan - International journal of molecular sciences, 2017 - mdpi.com
Psoriasis is a common and chronic inflammatory disease of the skin. It may impair the
physical and psychosocial function of patients and lead to decreased quality of life …

Psoriasis and comorbid diseases: Implications for management

J Takeshita, S Grewal, SM Langan, NN Mehta… - Journal of the American …, 2017 - Elsevier
As summarized in the first article in this continuing medical education series, the currently
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …

Efficacy and safety of risankizumab vs. secukinumab in patients with moderate‐to‐severe plaque psoriasis (IMMerge): results from a phase III, randomized, open‐label …

RB Warren, A Blauvelt, Y Poulin, S Beeck… - British Journal of …, 2021 - academic.oup.com
Background Patients with plaque psoriasis treated with biologic therapies need more
efficacious, safe and convenient treatments to improve quality of life. Risankizumab and …